06/09/2026
Sell side insight from Polaris Founder & CEO Diwakar Sinha:
One of the biggest misconceptions founders have about partnering with a strategic or private equity group is the belief that their role will shrink. In reality, the opposite is true. Your role becomes more important, not less. Your influence expands; it doesn't contract. Your leadership becomes the engine of the platform, not a relic of the past.
Before the transaction, you’re the operator. You’re the one putting out fires, managing day‑to‑day operations, solving problems, and carrying the weight of growth alone. After the transaction, your role changes. You become the architect. You shape the clinical and cultural vision. You mentor emerging leaders. You guide expansion. You influence platform‑level decisions. You move from doing to directing, from operator to strategist, from owner to platform builder.
Strategics and PE groups don’t buy EBITDA. They buy leadership. They buy culture. They buy the intangible elements that made your practice successful. Your culture becomes the blueprint for recruiting, onboarding, clinical standards, patient experience, and leadership development. You’re not stepping away from culture. You’re scaling it.
The founders who thrive after a transaction are the ones who understand that the deal isn’t a finish line. It’s a launchpad. Their influence grows. Their platform is expanding. Their leadership matters more, not less.
Your role doesn’t end when you partner with a Strategic or Private Equity group. It evolves. You’re not stepping back. You’re stepping into a role with more reach, more impact, and more strategic importance than ever before.
